3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Myelodysplastic Syndromes
8
Advanced Solid Tumors
8
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Ovarian Neoplasms
4
Neoplasms
4
Multiple Myeloma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Recurrence
3
Leukemia, Monocytic, Acute
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Advanced Lung Cancer
2
Interventions
Gemcitabine
31
Cisplatin
22
pembrolizumab
21
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
11
Mitomycin
10
enfortumab vedotin
9
avelumab
9
Cystoscopy
9
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
7
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Immunoglobulin G
5
Docetaxel
5
Disulfides
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Injections
×
90 days
×
Clear all
No trials found.